In vivo effects of TSH, TSH-receptor antibodies, and interferon-alpha-2b in xenografted human thyroid carcinoma.
Wenisch
H J
HJ
Department of Surgery, Johann Wolfgang Goethe-University, Frankfurt am Main/Germany.
Schumm-Draeger
P M
PM
Encke
A
A
D000818:Animals; D001323:Autoantibodies / Q000627:therapeutic use*; D002291:Carcinoma, Papillary / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D018828:Immunoglobulins, Thyroid-Stimulating; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011989:Receptors, Thyrotropin / Q000276:immunology*; D011994:Recombinant Proteins; D013964:Thyroid Neoplasms / Q000473:pathology* / Q000628:therapy*; D013972:Thyrotropin / Q000494:pharmacology*
D001323:Autoantibodies; D018828:Immunoglobulins, Thyroid-Stimulating; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011989:Receptors, Thyrotropin; D011994:Recombinant Proteins; D013972:Thyrotropin